Bio-Techne Corp Current Ratio 2006-2021 | TECH

Current and historical current ratio for Bio-Techne Corp (TECH) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Bio-Techne Corp current ratio for the three months ending June 30, 2021 was 3.35.
Bio-Techne Corp Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.51B $0.15B 3.35
2021-03-31 $0.57B $0.14B 4.12
2020-12-31 $0.54B $0.12B 4.61
2020-09-30 $0.54B $0.11B 5.14
2020-06-30 $0.52B $0.11B 4.88
2020-03-31 $0.49B $0.11B 4.69
2019-12-31 $0.47B $0.11B 4.43
2019-09-30 $0.39B $0.09B 4.44
2019-06-30 $0.41B $0.10B 4.05
2019-03-31 $0.42B $0.10B 4.32
2018-12-31 $0.38B $0.09B 4.35
2018-09-30 $0.38B $0.08B 4.59
2018-06-30 $0.40B $0.08B 5.01
2018-03-31 $0.39B $0.07B 5.55
2017-12-31 $0.35B $0.11B 3.10
2017-09-30 $0.31B $0.11B 2.87
2017-06-30 $0.35B $0.14B 2.57
2017-03-31 $0.31B $0.14B 2.15
2016-12-31 $0.29B $0.12B 2.44
2016-09-30 $0.31B $0.11B 2.90
2016-06-30 $0.25B $0.05B 4.69
2016-03-31 $0.24B $0.05B 5.08
2015-12-31 $0.26B $0.04B 7.21
2015-09-30 $0.24B $0.05B 5.35
2015-06-30 $0.25B $0.04B 6.24
2015-03-31 $0.30B $0.04B 7.65
2014-12-31 $0.27B $0.04B 6.18
2014-09-30 $0.27B $0.04B 6.60
2014-06-30 $0.47B $0.03B 17.79
2014-03-31 $0.32B $0.02B 13.12
2013-12-31 $0.28B $0.02B 12.63
2013-09-30 $0.28B $0.02B 13.84
2013-06-30 $0.41B $0.03B 12.76
2013-03-31 $0.39B $0.03B 12.01
2012-12-31 $0.36B $0.02B 16.91
2012-09-30 $0.35B $0.02B 15.29
2012-06-30 $0.35B $0.04B 9.69
2012-03-31 $0.31B $0.03B 9.97
2011-12-31 $0.23B $0.01B 16.09
2011-09-30 $0.22B $0.03B 8.35
2011-06-30 $0.23B $0.02B 12.67
2011-03-31 $0.28B $0.02B 16.73
2010-12-31 $0.25B $0.01B 18.55
2010-09-30 $0.23B $0.02B 14.52
2010-06-30 $0.20B $0.02B 11.81
2010-03-31 $0.22B $0.02B 11.11
2009-12-31 $0.30B $0.01B 21.99
2009-09-30 $0.28B $0.02B 17.57
2009-06-30 $0.26B $0.02B 16.46
2009-03-31 $0.22B $0.02B 14.93
2008-12-31 $0.19B $0.01B 14.82
2008-09-30 $0.25B $0.02B 12.95
2008-06-30 $0.26B $0.02B 12.77
2008-03-31 $0.26B $0.02B 12.86
2007-12-31 $0.24B $0.02B 11.98
2007-09-30 $0.23B $0.02B 15.62
2007-06-30 $0.21B $0.02B 12.38
2007-03-31 $0.19B $0.02B 12.25
2006-12-31 $0.17B $0.01B 13.75
2006-09-30 $0.16B $0.03B 5.91
2006-06-30 $0.15B $0.02B 8.34
2006-03-31 $0.14B $0.01B 10.79
2005-12-31 $0.13B $0.01B 9.50
2005-09-30 $0.13B $0.01B 10.56
2005-06-30 $0.14B $0.01B 9.63
2005-03-31 $0.11B $0.02B 6.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $20.829B $0.931B
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71